

ProMab Biotechnologies, Inc. Information
Summary
ProMab Biotechnologies, Inc. is a private company that has been in the industry for 24 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by John Wu. Its headquarters is located at Richmond, California, USA. The number of employees ranges from 25 to 100. The annual revenue of ProMab Biotechnologies, Inc. varies between 5.0M and 25M. Total funding of the company - $350K. To connect with ProMab Biotechnologies, Inc. employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
200-500 employees
Specialties
Monoclonal antibody production, Stem cell, and cancer stem cell specific monoclonals and research reagents, Recombinant protein expression in bacteria, insect, and mammalian systems, Polyclonal antibody production, CAR T-cell Products and Services, CAR NK-cell Products and Services, Antibody Engineering, Immunotherapy, Hybridoma Sequencing, Gene Synthesis, Contract Research Organization, Bispecific antibodies, scFv recombinant antibodies, Human phage display library, Human antibodies, T-cell activation beads, T-cell expansion media, peptide synthesis, Bispecific antibodies
SIC Code
2836
DMA Code
San Francisco Bay Area
Founded
2001
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Contact ProMab Biotechnologies, Inc.
Organization Website
Social Links
Phone Number
1-866-339-0871
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2001 | Privately Held | 100 - 250 | 40M | $350K | |
1998 | Privately Held | 25 - 100 | 7.5M | $350K | |
1998 | Public Company | 1.0K - 5.0K | 320.4M | $156.5M | |
2000 | Privately Held | 25 - 100 | 7.8M | $37.9M | |
2002 | Public Company | 1.0K - 5.0K | 390.8M | $1.1B | |
1997 | Privately Held | 25 - 100 | 10M | $150K | |
2001 | - | 100-200 | - | $- | |
2008 | - | 10-50 | - | $- | |
- | - | 1-10 | - | $- | |
- | - | 10-50 | - | $- |